ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Dividend Investing
Hoping to bag the record-high ResMed dividend? You better hurry!
Blue Chip Shares
5 top ASX 200 shares with 'no credible competition'
Blue Chip Shares
Buy CSL and these ASX 200 blue chip shares now
Opinions
Here's why I invested MORE money in ResMed shares last week
Broker Notes
Top brokers name 3 ASX shares to buy today
Healthcare Shares
2 of the best-performing ASX healthcare shares in 2024 so far
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
2 ASX 200 shares leaping higher on Monday even as the market crashes
Opinions
95% of ASX 200 stocks are bleeding today. Here are 2 I'd snap up
Share Gainers
Why Domino's, Encounter, Magnetic Resources, and ResMed shares are rising today
Broker Notes
Leading brokers name 3 ASX shares to buy today
Blue Chip Shares
Buy these top quality ASX 200 shares for your self-managed superannuation fund
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.